Clinical and epidemiological overview of hyperacute ischemic stroke patients treated with intravenous thrombolysis
Abstract Background Hyperacute ischemic stroke is a type of ischemic stroke that occurs rapidly and suddenly due to blockage of blood flow to the brain, with onset within 0–24 h. The recommended treatment for hyperacute ischemic stroke patients is a recombinant tissue plasminogen activator (rtPA) ac...
Saved in:
| Main Authors: | Lisda Amalia, Putri Qonitah |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-02-01
|
| Series: | The Egyptian Journal of Internal Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s43162-025-00419-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of risk factors for early neurological deterioration after intravenous thrombolysis in patients with acute ischemic stroke
by: Jungang Fang, et al.
Published: (2025-08-01) -
EXPERIENCE IN USING INTRAVENOUS THROMBOLYSIS IN ISCHEMIC STROKE
by: T. V. Demin, et al.
Published: (2010-03-01) -
Outcomes and risk factors for functional prognosis at 3 months after intravenous thrombolysis with r-tPA in patients with acute ischemic stroke: a retrospective cohort study
by: Yayun Xu, et al.
Published: (2025-03-01) -
Twenty‐Four‐Hour Post‐Thrombolysis NIHSS Score As the Strongest Prognostic Predictor After Acute Ischemic Stroke: ENCHANTED Study
by: Shoujiang You, et al.
Published: (2024-09-01) -
Interpretation of nursing guidelines for intravenous thrombolysis in acute ischemic stroke
by: Yawei Yu, et al.
Published: (2025-01-01)